MedTrace Logo

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

NCT01478412 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2011-12-07

No results posted yet for this study

Summary

This trial is to determine if prostate target delineation obtained through an ultrasound based system is equivalent in accuracy to the MRI image fusion, and if alignment correction vectors obtained from ultrasound imaging are of equivalent accuracy to orthogonal X-ray imaging for daily prostate positioning.

Conditions

  • Prostate Adenocarcinoma

Interventions

OTHER

Polymer based fiducial placement

Fiducial marker placement with rectal ultrasound imaging.

Sponsors & Collaborators

  • John Chang, MD

    lead OTHER

Principal Investigators

  • John Chang, MD · ProCure Proton Therapy Center

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478412 on ClinicalTrials.gov